IndraLab

Statements

PR-619 inhibits UCHL3. 1 / 1

| 1

reach

"Remarkably, only OTULIN binding was lost after treatment with the broad-spectrum DUB inhibitor PR-619, which also inhibits USP5 and UCHL3."

28919039

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

PR-619 inhibits UCHL3. 1 / 1

INDRA sources:

Databases

Reading